NO2914264T3 - - Google Patents

Info

Publication number
NO2914264T3
NO2914264T3 NO13776720A NO13776720A NO2914264T3 NO 2914264 T3 NO2914264 T3 NO 2914264T3 NO 13776720 A NO13776720 A NO 13776720A NO 13776720 A NO13776720 A NO 13776720A NO 2914264 T3 NO2914264 T3 NO 2914264T3
Authority
NO
Norway
Application number
NO13776720A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2914264T3 publication Critical patent/NO2914264T3/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO13776720A 2012-11-02 2013-10-04 NO2914264T3 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12007494 2012-11-02
PCT/EP2013/002998 WO2014067610A1 (en) 2012-11-02 2013-10-04 A 6-oxo-1,6-dihydro-pyridazine derivative for the use for the treatment of hepatocellular carcinoma (hcc)
EP13776720.8A EP2914264B1 (en) 2012-11-02 2013-10-04 A 6-oxo-1,6-dihydro-pyridazine derivative for the use for the treatment of hepatocellular carcinoma (hcc)

Publications (1)

Publication Number Publication Date
NO2914264T3 true NO2914264T3 (ko) 2018-01-06

Family

ID=47143496

Family Applications (1)

Application Number Title Priority Date Filing Date
NO13776720A NO2914264T3 (ko) 2012-11-02 2013-10-04

Country Status (26)

Country Link
US (1) US20150283137A1 (ko)
EP (1) EP2914264B1 (ko)
JP (1) JP6255028B2 (ko)
KR (1) KR102131588B1 (ko)
CN (1) CN104768553A (ko)
AR (1) AR093318A1 (ko)
AU (1) AU2013339823B2 (ko)
BR (1) BR112015008279A2 (ko)
CA (1) CA2890273C (ko)
DK (1) DK2914264T3 (ko)
ES (1) ES2646913T3 (ko)
HK (1) HK1211869A1 (ko)
HR (1) HRP20171295T1 (ko)
HU (1) HUE035483T2 (ko)
IL (1) IL238536B (ko)
LT (1) LT2914264T (ko)
MX (1) MX354518B (ko)
NO (1) NO2914264T3 (ko)
PL (1) PL2914264T3 (ko)
PT (1) PT2914264T (ko)
RS (1) RS56485B1 (ko)
RU (1) RU2650679C2 (ko)
SG (1) SG11201503214YA (ko)
SI (1) SI2914264T1 (ko)
WO (1) WO2014067610A1 (ko)
ZA (1) ZA201503924B (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015022782A1 (ja) 2013-08-14 2015-02-19 有限会社ジャパン通商 水耕栽培システム、および該水耕栽培システムと発泡スチロール製ハウスとを備えた植物工場
PL3996688T3 (pl) * 2019-07-10 2024-02-12 Merck Patent Gmbh Preparat farmaceutyczny

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005057924A1 (de) * 2005-12-05 2007-06-06 Merck Patent Gmbh Pyridazinonderivate
DE102007032507A1 (de) * 2007-07-12 2009-04-02 Merck Patent Gmbh Pyridazinonderivate
CA2949515C (en) * 2009-01-08 2018-10-23 Axel Becker Polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof

Also Published As

Publication number Publication date
IL238536A0 (en) 2015-06-30
RU2650679C2 (ru) 2018-04-17
JP2015536957A (ja) 2015-12-24
WO2014067610A1 (en) 2014-05-08
BR112015008279A2 (pt) 2017-07-04
MX2015005265A (es) 2015-07-17
PL2914264T3 (pl) 2017-12-29
SG11201503214YA (en) 2015-05-28
ES2646913T3 (es) 2017-12-18
CN104768553A (zh) 2015-07-08
PT2914264T (pt) 2017-11-14
KR20150079942A (ko) 2015-07-08
SI2914264T1 (sl) 2017-12-29
LT2914264T (lt) 2017-11-10
US20150283137A1 (en) 2015-10-08
RU2015120692A (ru) 2016-12-27
KR102131588B1 (ko) 2020-07-08
IL238536B (en) 2019-01-31
CA2890273C (en) 2021-10-26
AU2013339823A1 (en) 2015-06-18
DK2914264T3 (en) 2017-09-11
AR093318A1 (es) 2015-05-27
AU2013339823B2 (en) 2018-01-04
EP2914264A1 (en) 2015-09-09
JP6255028B2 (ja) 2017-12-27
HUE035483T2 (hu) 2018-05-02
ZA201503924B (en) 2020-11-25
HRP20171295T1 (hr) 2017-10-20
EP2914264B1 (en) 2017-08-09
RS56485B1 (sr) 2018-01-31
HK1211869A1 (en) 2016-06-03
CA2890273A1 (en) 2014-05-08
MX354518B (es) 2018-03-08

Similar Documents

Publication Publication Date Title
BR112014024221A2 (ko)
BR112014017614A2 (ko)
BR112014017625A2 (ko)
BR112014017592A2 (ko)
AR092201A1 (ko)
BR112014017607A2 (ko)
BR112014024833A2 (ko)
BR112014019268A2 (ko)
BR112014018938A2 (ko)
BR112014017609A2 (ko)
BR112014017588A2 (ko)
BR112014017618A2 (ko)
BR112014013184A8 (ko)
BR112014019282A2 (ko)
BR112014018782A2 (ko)
BR112014017808A2 (ko)
BR112014017621A2 (ko)
BR112014017622A2 (ko)
BR112014018300A2 (ko)
BR112014017627A2 (ko)
BR112014017623A2 (ko)
BR112014017989A2 (ko)
BR112014018166A2 (ko)
BR112014017600A2 (ko)
BR112014017671A2 (ko)